2018
Same-day confirmation of intrauterine pregnancy failure in women with first- and early second-trimester bleeding
Mor A, Tal R, Haberman S, Kalgi B, Nasab SH, Minkoff H. Same-day confirmation of intrauterine pregnancy failure in women with first- and early second-trimester bleeding. Fertility And Sterility 2018, 109: 1060-1064. PMID: 29935643, DOI: 10.1016/j.fertnstert.2018.02.006.Peer-Reviewed Original ResearchMeSH KeywordsAbortion, IncompleteAbortion, LegalAbortion, SpontaneousAbortion, ThreatenedAdultAlpha-FetoproteinsBlood Chemical AnalysisCerclage, CervicalDilatation and CurettageFemaleHumansMaternal Serum Screening TestsPregnancyPregnancy Trimester, FirstPregnancy Trimester, SecondReproducibility of ResultsSensitivity and SpecificityTime FactorsUterine HemorrhageVaginaConceptsMaternal serumVaginal bloodVaginal bleedingFetal tissuesSecond trimester bleedingProspective cohort studyAlpha-fetoprotein concentrationAFP concentrationProducts of conceptionGroup of womenCerclage groupCerclage placementCohort studyIncomplete miscarriagePregnancy failureMedical CenterMAIN OUTCOMEBleedingMiscarriageBloodSerumAFPTissueWomenCharacteristic analysis
2016
A Novel Rapid Bedside Test for Rupture of Membranes [25I]
Mor A, Tal R, Irani M, Sabharwal A, Kalgi B, Minkoff H. A Novel Rapid Bedside Test for Rupture of Membranes [25I]. Obstetrics And Gynecology 2016, 127: 79s-80s. DOI: 10.1097/01.aog.0000483729.29770.4b.Peer-Reviewed Original ResearchRupture of membranesNormal vaginal dischargeAmniotic fluid leakageBedside testAlpha-fetoproteinPregnant womenVaginal dischargeFluid leakageUrine pregnancy testProspective cohort studyReliable bedside testQualitative immunoassayRapid bedside testNegative resultsIntact membranesVaginal bleedingCohort studyInfertility clinicPregnancy testStudy groupUrine specimensHome testWomenPositive resultsImmunoassay
2015
Carcinoembryonic antigen as a biomarker for meconium‐stained amniotic fluid
Mor A, Tal R, Irani M, McCalla S, Haberman S, Garg D, Wajntraub B. Carcinoembryonic antigen as a biomarker for meconium‐stained amniotic fluid. International Journal Of Gynecology & Obstetrics 2015, 132: 329-331. PMID: 26674317, DOI: 10.1016/j.ijgo.2015.07.032.Peer-Reviewed Original ResearchConceptsMeconium-stained amniotic fluidClear amniotic fluidAmniotic fluidCEA concentrationHigh CEA concentrationsMean CEA concentrationsTerm singleton pregnanciesProspective cohort studyRupture of membranesClear medical indicationCarcinoembryonic antigen concentrationCharacteristic curve analysisAmniotic fluid statusCEA cutoffSingleton pregnanciesCohort studyArtificial ruptureBedside testFluid statusNormal rangeMedical indicationsCarcinoembryonic antigenAntigen concentrationCurve analysisOnly womenAlpha-Fetoprotein as a Tool to Distinguish Amniotic Fluid From Urine, Vaginal Discharge, and Semen
Mor A, Tal R, Haberman S, McCalla S, Irani M, Perlman J, Seifer DB, Minkoff H. Alpha-Fetoprotein as a Tool to Distinguish Amniotic Fluid From Urine, Vaginal Discharge, and Semen. Obstetrics And Gynecology 2015, 125: 448-452. PMID: 25569004, DOI: 10.1097/aog.0000000000000635.Peer-Reviewed Original ResearchConceptsNormal vaginal dischargeAlpha-fetoprotein concentrationDiagnosis of ruptureVaginal dischargeAmniotic fluidAlpha-fetoproteinPregnant womenReceiver operator characteristic curve analysisSanitary padsOperator characteristic curve analysisProspective cohort studyAlpha-fetoprotein levelsAmniotic fluid levelsCharacteristic curve analysisAmniotic fluid specimensCohort studyInfertility evaluationMaternal urineAFP levelsFluid specimensFluid levelsSemen specimensCurve analysisUrineAFP quantification
2014
Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes
Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. American Journal Of Obstetrics And Gynecology 2014, 211: 59.e1-59.e8. PMID: 24593938, DOI: 10.1016/j.ajog.2014.02.026.Peer-Reviewed Original ResearchConceptsSerum antimüllerian hormone levelsAntimüllerian hormone levelsClinical pregnancy ratePopulation of womenAMH levelsPregnancy rateHormone levelsHigher clinical pregnancy rateElevated AMH levelsPresence of amenorrheaMultiple pregnancy rateOvarian hyperstimulation syndromeRetrospective cohort studyHigher AMH levelsPolycystic ovarian morphologyPolycystic ovarian syndromeSyndrome phenotypeReproductive technology outcomesHyperstimulation syndromePCOS severityClinical pregnancyOvarian stimulationTotal testosteroneCohort studyOvarian syndrome